I. Invs, Projection de l'incidence et de la mortalité par cancer en France en 2011 Rapport technique [Internet] Institut de veille sanitaire Disponible sur: http://www.invs.sante.fr/Publications-et-outils/Rapports-et-syntheses/Maladies- chroniques-et-traumatismes, 2011.

B. Smith, G. Smith, A. Hurria, G. Hortobagyi, and T. Buchholz, Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation, Journal of Clinical Oncology, vol.27, issue.17, p.275865, 2009.
DOI : 10.1200/JCO.2008.20.8983

. Inca, Etat des lieux et perspectives en oncogériatrie Disponible sur: http://www.google.fr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CCMQFjA A&url=http%3A%2F%2Fwww.e- cancer.fr%2Fcomponent%2Fdocman%2Fdoc_download%2F9563-etat-des-lieux-et- perspectives-en- oncogeriatrie&ei=G3PbVOiVEImw7AbWzoDoBA&usg=AFQjCNHJFhXy_iZnPIToW MwT7yvjwmgo-A, 2009.

J. Escourrou, R. Laugier, D. Heresbach, J. Arpurt, T. Barrioz et al., Consensus en endoscopie digestive (CED) Acta Endosc, p.11621, 2009.

F. Rodríguez-gonzález, A. Naranjo-rodríguez, I. Mata-tapia, M. Chicano-gallardo, J. Puente-gutierrez et al., ERCP in patients 90 years of age and older, Gastrointestinal Endoscopy, vol.58, issue.2, p.2205, 2003.
DOI : 10.1067/mge.2003.363

C. Ashton, W. Mcnabb, M. Wilkinson, and R. Lewis, Endoscopic retrograde cholangiopancreatography in elderly patients, Age and Ageing, vol.27, issue.6, p.6838, 1998.
DOI : 10.1093/ageing/27.6.683

E. Fritz, A. Kirchgatterer, D. Hubner, G. Aschl, M. Hinterreiter et al., ERCP is safe and effective in patients 80 years of age and older compared with younger patients, Gastrointestinal Endoscopy, vol.64, issue.6, p.899905, 2006.
DOI : 10.1016/j.gie.2006.05.010

J. Kim, B. Cha, S. Lee, Y. Park, J. Kim et al., Safety and Efficacy of Endoscopic Retrograde Cholangiopancreatograpy in Very Elderly Patients, The Korean Journal of Gastroenterology, vol.57, issue.4, p.23742, 2011.
DOI : 10.4166/kjg.2011.57.4.237

D. Yun, J. Han, J. Oh, K. Park, I. Shin et al., Is endoscopic retrograde cholangiopancreatography safe in patients 90 years of age and older? Gut Liver, sept, vol.8, issue.5, p.5526, 2014.

F. Lukens, D. Howell, S. Upender, S. Sheth, and S. Jafri, ERCP in the Very Elderly: Outcomes Among Patients Older than Eighty, Digestive Diseases and Sciences, vol.51, issue.3, p.84751, 2010.
DOI : 10.1007/s10620-009-0784-6

P. Katsinelos, G. Paroutoglou, J. Kountouras, C. Zavos, A. Beltsis et al., Efficacy and safety of therapeutic ERCP in patients 90 years of age and older, Gastrointestinal Endoscopy, vol.63, issue.3, p.41723, 2006.
DOI : 10.1016/j.gie.2005.09.051

I. Globocan, Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012, 2012.

C. Eheman, S. Henley, R. Ballard-barbash, E. Jacobs, M. Schymura et al., Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity, Cancer, vol.16, issue.suppl 2, p.233866, 2012.
DOI : 10.1002/cncr.27514

T. André, Cancer du pancréas [Internet]. Thésaurus National de Cancérologie Digestive, Disponible sur, 2011.

J. Delpero, Cancer du pancréas: rapport présenté au 112e Congrès français de chirurgie, Paris, 6 -8 octobre 2010. Monographies de l'Association française de chirurgie, 2010.

E. Kruse, Palliation in Pancreatic Cancer, Surgical Clinics of North America, vol.90, issue.2, p.35564, 2010.
DOI : 10.1016/j.suc.2009.12.004

D. Malka, Cancer des voies biliaires [Internet]. Thésaurus National de Cancérologie Digestive, Disponible sur, 2014.

Y. Shaib and H. El-serag, The Epidemiology of Cholangiocarcinoma, Seminars in Liver Disease, vol.24, issue.2, p.11525, 2004.
DOI : 10.1055/s-2004-828889

T. André, . Jfhod, and . Snfge, org -Société savante médicale française d'hépatogastroentérologie et d'oncologie digestive

S. Iodice, S. Gandini, P. Maisonneuve, and A. Lowenfels, Tobacco and the risk of pancreatic cancer: a review and meta-analysis, Langenbeck's Archives of Surgery, vol.67, issue.4, p.53545, 2008.
DOI : 10.1007/s00423-007-0266-2

U. Nöthlings, L. Wilkens, S. Murphy, J. Hankin, B. Henderson et al., Meat and Fat Intake as Risk Factors for Pancreatic Cancer: The Multiethnic Cohort Study, JNCI Journal of the National Cancer Institute, vol.97, issue.19, p.145865, 2005.
DOI : 10.1093/jnci/dji292

D. Michaud, E. Giovannucci, W. Willett, G. Colditz, M. Stampfer et al., Physical Activity, Obesity, Height, and the Risk of Pancreatic Cancer, JAMA, vol.286, issue.8, p.9219, 2001.
DOI : 10.1001/jama.286.8.921

R. Stolzenberg-solomon, B. Graubard, S. Chari, P. Limburg, P. Taylor et al., Insulin, Glucose, Insulin Resistance, and Pancreatic Cancer in Male Smokers, JAMA, vol.294, issue.22, p.28728, 2005.
DOI : 10.1001/jama.294.22.2872

P. Pothiwala, S. Jain, and S. Yaturu, Metabolic Syndrome and Cancer, Metabolic Syndrome and Related Disorders, vol.7, issue.4, p.27988, 2009.
DOI : 10.1089/met.2008.0065

J. Elena, E. Steplowski, K. Yu, P. Hartge, G. Tobias et al., Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium, Cancer Causes & Control, vol.129, issue.7, p.1325, 2013.
DOI : 10.1007/s10552-012-0078-8

O. Neill, S. , O. Driscoll, and L. , Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies, Obes Rev Off J Int Assoc Study Obes. janv, vol.16, issue.1, p.112, 2015.

G. Reeves, K. Pirie, V. Beral, J. Green, E. Spencer et al., Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study, BMJ, vol.335, issue.7630, p.1134, 2007.
DOI : 10.1136/bmj.39367.495995.AE

S. Larsson, N. Orsini, and A. Wolk, Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies, International Journal of Cancer, vol.15, issue.9, 2007.
DOI : 10.1002/ijc.22535

J. Bae, E. Lee, and G. Guyatt, Citrus Fruit Intake and Pancreatic Cancer Risk, Pancreas, vol.38, issue.2, p.16874, 2009.
DOI : 10.1097/MPA.0b013e318188c497

R. Siegel, D. Naishadham, and A. Jemal, Cancer statistics, 2012, CA: A Cancer Journal for Clinicians, vol.287, issue.suppl 5, p.1029, 2012.
DOI : 10.3322/caac.20138

M. David, C. Lepage, J. Jouve, V. Jooste, M. Chauvenet et al., Management and prognosis of pancreatic cancer over a 30-year period, British Journal of Cancer, vol.101, issue.2, p.2158, 2009.
DOI : 10.1038/sj.bjc.6604436

H. Burris, M. Moore, J. Andersen, M. Green, M. Rothenberg et al., Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial., Journal of Clinical Oncology, vol.15, issue.6, p.240313, 1997.
DOI : 10.1200/JCO.1997.15.6.2403

T. Conroy, F. Desseigne, M. Ychou, O. Bouché, R. Guimbaud et al., FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer, N Engl J Med. 12 mai, vol.364, p.181725, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00598658

V. Hoff, D. Ervin, T. Arena, F. Chiorean, E. Infante et al., Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine, N Engl J Med. 31 oct, vol.369, issue.18, p.1691703, 2013.

P. Peddi, S. Lubner, R. Mcwilliams, B. Tan, J. Picus et al., Multiinstitutional experience with FOLFIRINOX in pancreatic adenocarcinoma, JOP J Pancreas. sept, vol.13, issue.5, p.497501, 2012.

T. Barrioz, Medical management of cholangiocarcinoma], Gastroentérologie Clin Biol. janv, vol.28, issue.1, p.5765, 2004.

J. Pereira-lima, R. Jakobs, M. Maier, C. Benz, B. Kohler et al., Endoscopic biliary stenting for the palliation of pancreatic cancer: results, survival predictive factors, and comparison of 10-French with 11.5-French gauge stents, Am J Gastroenterol. oct, vol.91, issue.10, p.217984, 1996.

C. Soderlund and S. Linder, Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial, Gastrointestinal Endoscopy, vol.63, issue.7, p.98695, 2006.
DOI : 10.1016/j.gie.2005.11.052

F. Prat, O. Chapat, B. Ducot, T. Ponchon, J. Fritsch et al., Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline, Gut, vol.42, issue.1, p.7680, 1998.
DOI : 10.1136/gut.42.1.76

G. Nix, C. Dubbelman, J. Wilson, H. Schütte, J. Jeekel et al., Prognostic implications of tumor diameter in carcinoma of the head of the pancreas, Cancer, vol.53, issue.2, p.52935, 1991.
DOI : 10.1002/1097-0142(19910115)67:2<529::AID-CNCR2820670235>3.0.CO;2-3

I. Has, ALD n°30 -Cancer du pancréas Disponible sur: http://www.has-sante.fr/portail, pp.2010-2022, 2010.

H. Baumel, M. Huguier, J. Manderscheid, J. Fabre, S. Houry et al., Results of resection for cancer of the exocrine pancreas: A study from the French Association of Surgery, British Journal of Surgery, vol.59, issue.1, p.1027, 1994.
DOI : 10.1002/bjs.1800810138

M. Extermann, M. Aapro, R. Bernabei, H. Cohen, J. Droz et al., Use of comprehensive geriatric assessment in older cancer patients:, Critical Reviews in Oncology/Hematology, vol.55, issue.3, p.24152, 2005.
DOI : 10.1016/j.critrevonc.2005.06.003

H. Wildiers, P. Heeren, M. Puts, E. Topinkova, M. Janssen-heijnen et al., International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer, Journal of Clinical Oncology, vol.32, issue.24, 2014.
DOI : 10.1200/JCO.2013.54.8347

F. Maire, P. Hammel, P. Ponsot, A. A. , O. Toole et al., Long-term Outcome of Biliary and Duodenal Stents in Palliative Treatment of Patients with Unresectable Adenocarcinoma of the Head of Pancreas, The American Journal of Gastroenterology, vol.36, issue.4, p.73542, 2006.
DOI : 10.1007/s004649901174

A. Das and M. Sivak, Endoscopic palliation for inoperable pancreatic cancer, Cancer Control J Moffitt Cancer Cent. oct, vol.7, issue.5, p.4527, 2000.

H. Shepherd, G. Royle, A. Ross, A. Diba, M. Arthur et al., Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: A randomized trial, British Journal of Surgery, vol.152, issue.12, p.11668, 1988.
DOI : 10.1002/bjs.1800751207

J. Andersen, S. Sørensen, A. Kruse, M. Rokkjaer, and P. Matzen, Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice., Gut, vol.30, issue.8, p.11325, 1989.
DOI : 10.1136/gut.30.8.1132

K. Lillemoe, J. Cameron, J. Hardacre, T. Sohn, P. Sauter et al., Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial, Ann Surg. sept, vol.230, issue.32830, p.3228, 1999.

A. Smith, J. Dowsett, R. Russell, A. Hatfield, and P. Cotton, Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction, Lancet. 17 déc, vol.344, issue.8938, p.165560, 1994.

A. Moss, E. Morris, J. Leyden, and P. Macmathuna, Malignant distal biliary obstruction: A systematic review and meta-analysis of endoscopic and surgical bypass results, Cancer Treatment Reviews, vol.33, issue.2, p.21321, 2007.
DOI : 10.1016/j.ctrv.2006.10.006

E. Artifon, P. Sakai, J. Cunha, A. Dupont, F. Filho et al., Surgery or Endoscopy for Palliation of Biliary Obstruction Due to Metastatic Pancreatic Cancer, The American Journal of Gastroenterology, vol.7, issue.9, p.20317, 2006.
DOI : 10.1097/00000658-199909000-00005

J. Dumonceau, A. Tringali, D. Blero, J. Devière, R. Laugiers et al., Biliary stenting: Indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline, Endoscopy, vol.44, issue.03, p.27798, 2012.
DOI : 10.1055/s-0031-1291633

A. Speer, P. Cotton, R. Russell, R. Mason, A. Hatfield et al., RANDOMISED TRIAL OF ENDOSCOPIC VERSUS PERCUTANEOUS STENT INSERTION IN MALIGNANT OBSTRUCTIVE JAUNDICE, The Lancet, vol.330, issue.8550, p.5762, 1987.
DOI : 10.1016/S0140-6736(87)92733-4

V. Piñol, A. Castells, J. Bordas, M. Real, J. Llach et al., Percutaneous selfexpanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial, Radiology. oct, vol.225, issue.1, p.2734, 2002.

S. Mahgerefteh, A. Hubert, A. Klimov, and A. Bloom, Clinical Impact of Percutaneous Transhepatic Insertion of Metal Biliary Endoprostheses for Palliation of Jaundice and Facilitation of Chemotherapy, American Journal of Clinical Oncology, vol.38, issue.5, 2013.
DOI : 10.1097/COC.0b013e3182a5341a

P. Davids, A. Groen, E. Rauws, G. Tytgat, and K. Huibregtse, Randomised trial of selfexpanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet, déc, vol.340, pp.8834-8835148892, 1992.

N. Stern and R. Sturgess, Endoscopic therapy in the management of malignant biliary obstruction, European Journal of Surgical Oncology (EJSO), vol.34, issue.3, p.3137, 2008.
DOI : 10.1016/j.ejso.2007.07.210

C. Locke and D. , Multicentre randomised trial of wallstent biliary endoprothesis versus plastic stent, p.3106, 1993.

K. Knyrim, H. Wagner, J. Pausch, and N. Vakil, A Prospective, Randomized, Controlled Trial of Metal Stents for Malignant Obstruction of the Common Bile Duct, Endoscopy, vol.25, issue.03, p.20712, 1993.
DOI : 10.1055/s-2007-1010294

F. Prat, O. Chapat, B. Ducot, T. Ponchon, G. Pelletier et al., A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct, Gastrointestinal Endoscopy, vol.47, issue.1, p.17, 1998.
DOI : 10.1016/S0016-5107(98)70291-3

E. Kullman, F. Frozanpor, C. Söderlund, S. Linder, P. Sandström et al., Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study, Gastrointestinal Endoscopy, vol.72, issue.5, p.91523, 2010.
DOI : 10.1016/j.gie.2010.07.036

J. Lee, S. Krishna, A. Singh, H. Ladha, R. Slack et al., Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in??749 patients, Gastrointestinal Endoscopy, vol.78, issue.2, p.31224, 2013.
DOI : 10.1016/j.gie.2013.02.032

B. Boulay and M. Parepally, Managing malignant biliary obstruction in pancreas cancer: choosing the appropriate strategy, World J Gastroenterol WJG. 28 juill, vol.20, issue.28, p.934553, 2014.

A. Tringali, M. Mutignani, A. Milano, V. Perri, and G. Costamagna, No difference between supine and prone position for ERCP in conscious sedated patients: a prospective randomized study, Endoscopy, vol.40, issue.2, p.937, 2008.
DOI : 10.1055/s-2007-995317

E. Williams, S. Taylor, P. Fairclough, A. Hamlyn, R. Logan et al., Are we meeting the standards set for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice, Gut, vol.56, issue.6, p.8219, 2007.
DOI : 10.1136/gut.2006.097543

K. Raymondos, B. Panning, I. Bachem, M. Manns, S. Piepenbrock et al., Evaluation of Endoscopic Retrograde Cholangiopancreatography Under Conscious Sedation and General Anesthesia, Endoscopy, vol.34, issue.9, p.7216, 2002.
DOI : 10.1055/s-2002-33567

S. Motte, J. Deviere, J. Dumonceau, E. Serruys, J. Thys et al., Risk factors for septicemia following endoscopic biliary stenting, Gastroenterology, vol.101, issue.5, p.137481, 1991.
DOI : 10.1016/0016-5085(91)90091-X

P. Cotton, D. Garrow, J. Gallagher, and J. Romagnuolo, Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years, Gastrointestinal Endoscopy, vol.70, issue.1, p.808, 2009.
DOI : 10.1016/j.gie.2008.10.039

M. Freeman, D. Nelson, S. Sherman, G. Haber, M. Herman et al., Complications of Endoscopic Biliary Sphincterotomy, New England Journal of Medicine, vol.335, issue.13, p.90918, 1996.
DOI : 10.1056/NEJM199609263351301

E. Christoforidis, I. Goulimaris, I. Kanellos, K. Tsalis, C. Demetriades et al., Post-ERCP Pancreatitis and Hyperamylasemia: Patient-Related and Operative Risk Factors, Endoscopy, vol.34, issue.4, p.28692, 2002.
DOI : 10.1055/s-2002-23630

C. Boustière, A. Veitch, G. Vanbiervliet, P. Bulois, P. Deprez et al., Endoscopy and antiplatelet agents, European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. mai, vol.43, issue.5, p.44561, 2011.

M. Sarr and J. Cameron, Surgical management of unresectable carcinoma of the pancreas, Surgery. févr, vol.91, issue.2, p.12333, 1982.

A. Ballinger, M. Mchugh, S. Catnach, E. Alstead, and M. Clark, Symptom relief and quality of life after stenting for malignant bile duct obstruction., Gut, vol.35, issue.4, p.46770, 1994.
DOI : 10.1136/gut.35.4.467

W. Luman, A. Cull, and K. Palmer, Quality of life in patients stented for malignant biliary obstructions, European Journal of Gastroenterology & Hepatology, vol.9, issue.5, p.4814, 1997.
DOI : 10.1097/00042737-199705000-00013

N. Abraham, J. Barkun, and A. Barkun, Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life, Gastrointest Endosc. déc, vol.56, issue.6, p.83541, 2002.

O. Barkay, P. Mosler, C. Schmitt, G. Lehman, J. Frakes et al., Effect of Endoscopic Stenting of Malignant Bile Duct Obstruction on Quality of Life, Journal of Clinical Gastroenterology, vol.47, issue.6, p.52631, 2013.
DOI : 10.1097/MCG.0b013e318272440e

E. Christoforidis, K. Vasiliadis, K. Blouhos, K. Tsalis, E. Tsorlini et al., Feasibility of therapeutic endoscopic retrograde cholangiopancreatography for bile duct stones in nonagenarians: a single unit audit, J Gastrointest Liver Dis JGLD. déc, vol.17, issue.4, p.42732, 2008.

J. Bergman, E. Rauws, J. Tijssen, G. Tytgat, and K. Huibregtse, Biliary endoprostheses in elderly patients with endoscopically irretrievable common bile duct stones: Report on 117 patients, Gastrointestinal Endoscopy, vol.42, issue.3, 1995.
DOI : 10.1016/S0016-5107(95)70091-9

T. Nishikawa, T. Tsuyuguchi, Y. Sakai, H. Sugiyama, D. Sakamoto et al., Old age is associated with increased severity of complications in endoscopic biliary stone removal, Digestive Endoscopy, vol.39, issue.4, p.56976, 2014.
DOI : 10.1111/den.12213

P. Cotton, G. Eisen, L. Aabakken, T. Baron, M. Hutter et al., A lexicon for endoscopic adverse events: report of an ASGE workshop, Gastrointestinal Endoscopy, vol.71, issue.3, p.44654, 2010.
DOI : 10.1016/j.gie.2009.10.027

T. Glomsaker, G. Hoff, J. Kvaløy, K. Søreide, L. Aabakken et al., Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography, British Journal of Surgery, vol.42, issue.Suppl, p.37380, 2013.
DOI : 10.1002/bjs.8992

M. Kaassis, J. Boyer, R. Dumas, T. Ponchon, D. Coumaros et al., Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study, Gastrointestinal Endoscopy, vol.57, issue.2, p.17882, 2003.
DOI : 10.1067/mge.2003.66

S. Strasberg, F. Gao, D. Sanford, D. Linehan, W. Hawkins et al., Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas, HPB, vol.16, issue.2, p.1506, 2014.
DOI : 10.1111/hpb.12094

L. Balducci and M. Extermann, Management of Cancer in the Older Person: A Practical Approach, The Oncologist, vol.5, issue.3, p.22437, 2000.
DOI : 10.1634/theoncologist.5-3-224

S. Legrain, Consommation médicamenteuse chez le sujet âgé. HAS, 2005.

D. Qato, G. Alexander, R. Conti, M. Johnson, P. Schumm et al., Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States, JAMA. 24 déc, vol.300, issue.24, p.286778, 2008.

R. Riechelmann, F. Moreira, O. Smaletz, and E. Saad, Potential for drug interactions in hospitalized cancer patients, Cancer Chemotherapy and Pharmacology, vol.77, issue.3, p.28690, 2005.
DOI : 10.1007/s00280-004-0998-4

C. Bellera, M. Rainfray, S. Mathoulin-pélissier, C. Mertens, F. Delva et al., Screening older cancer patients: first evaluation of the G-8 geriatric screening tool, Annals of Oncology, vol.23, issue.8, p.216672, 2012.
DOI : 10.1093/annonc/mdr587

L. Balducci and C. Beghe, The application of the principles of geriatrics to the management of the older person with cancer, Critical Reviews in Oncology/Hematology, vol.35, issue.3, p.14754, 2000.
DOI : 10.1016/S1040-8428(00)00089-5

C. Winograd, M. Gerety, M. Chung, M. Goldstein, F. Dominguez et al., Screening for Frailty: Criteria and Predictors of Outcomes, Journal of the American Geriatrics Society, vol.28, issue.II, p.77884, 1991.
DOI : 10.1111/j.1532-5415.1991.tb02700.x

J. Morley, Why Do Physicians Fail to Recognize and Treat Malnutrition in Older Persons?, Journal of the American Geriatrics Society, vol.13, issue.12, p.113940, 1991.
DOI : 10.1111/j.1532-5415.1991.tb02884.x

A. Newman, D. Yanez, T. Harris, A. Duxbury, P. Enright et al., Weight Change in Old Age and its Association with Mortality, Journal of the American Geriatrics Society, vol.68, issue.10, p.130918, 2001.
DOI : 10.1001/jama.281.16.1498

J. Wallace, R. Schwartz, A. Lacroix, R. Uhlmann, and R. Pearlman, Involuntary Weight Loss in Older Outpatients: Incidence and Clinical Significance, Journal of the American Geriatrics Society, vol.118, issue.Suppl, p.32937, 1995.
DOI : 10.1111/j.1532-5415.1995.tb05803.x

M. Extermann and A. Hurria, Comprehensive geriatric assessment for older patients with cancer, J Clin Oncol Off J Am Soc Clin Oncol. 10 mai, vol.25, issue.14, p.182431, 2007.

W. Dewys, C. Begg, P. Lavin, P. Band, J. Bennett et al., Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group, Am J Med. oct, vol.69, issue.4, p.4917, 1980.

C. Yuan, Y. Bao, C. Wu, P. Kraft, S. Ogino et al., Prediagnostic Body Mass Index and Pancreatic Cancer Survival, Journal of Clinical Oncology, vol.31, issue.33, p.422934, 2013.
DOI : 10.1200/JCO.2013.51.7532

M. Charlson, P. Pompei, K. Ales, and C. Mackenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation, Journal of Chronic Diseases, vol.40, issue.5, p.37383, 1987.
DOI : 10.1016/0021-9681(87)90171-8

M. Charlson, T. Szatrowski, J. Peterson, and J. Gold, Validation of a combined comorbidity index, Journal of Clinical Epidemiology, vol.47, issue.11, p.124551, 1994.
DOI : 10.1016/0895-4356(94)90129-5

M. Extermann, Measuring comorbidity in older cancer patients, European Journal of Cancer, vol.36, issue.4, p.45371, 1990.
DOI : 10.1016/S0959-8049(99)00319-6

R. Singh, O. Brien, and T. , Comorbidity Assessment in Localized Prostate Cancer: A Review of Currently Available Techniques, European Urology, vol.46, issue.1, p.2841, 2004.
DOI : 10.1016/j.eururo.2004.01.010

W. Frenkel, E. Jongerius, M. Mandjes-van-uitert, B. Van-munster, and S. De-rooij, Validation of the Charlson Comorbidity Index in Acutely Hospitalized Elderly Adults: A Prospective Cohort Study, Journal of the American Geriatrics Society, vol.43, issue.2, p.3426, 2014.
DOI : 10.1111/jgs.12635

N. Martínez-velilla and D. Zekry, Charlson Comorbidity Index in Acutely Hospitalized Elderly Adults, Journal of the American Geriatrics Society, vol.62, issue.8, p.16145, 2014.
DOI : 10.1111/jgs.12951

D. Zekry, L. Valle, B. Lardi, C. Graf, C. Michel et al., Geriatrics index of comorbidity was the most accurate predictor of death in geriatric hospital among six comorbidity scores, Journal of Clinical Epidemiology, vol.63, issue.9, p.103644, 2010.
DOI : 10.1016/j.jclinepi.2009.11.013

T. Mura, J. Dartigues, and C. Berr, How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050, European Journal of Neurology, vol.344, issue.2, p.2529, 2010.
DOI : 10.1111/j.1468-1331.2009.02783.x

URL : https://hal.archives-ouvertes.fr/inserm-00426844

M. Folstein, S. Folstein, and P. Mchugh, « Mini-mental state ». A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res. nov, vol.12, issue.3, p.18998, 1975.